simvastatin has been researched along with Psoriasis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
DʼAcunto, K; Sismour, B | 1 |
Al Salman, M; Azizpour, A; Farid, AS; Ghiasi, M; Mahmoudi, H; Taraz, M | 1 |
Colsman, A; Sticherling, M | 1 |
White, KL | 1 |
Shirinsky, IV; Shirinsky, VS | 1 |
1 trial(s) available for simvastatin and Psoriasis
Article | Year |
---|---|
Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: A randomized controlled trial.
Topics: Combined Modality Therapy; Humans; Psoriasis; Quality of Life; Severity of Illness Index; Simvastatin; Treatment Outcome; Ultraviolet Therapy | 2021 |
4 other study(ies) available for simvastatin and Psoriasis
Article | Year |
---|---|
Down syndrome, severe psoriasis, and increased risk for cardiovascular events.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Down Syndrome; Fatal Outcome; Female; Heart Septal Defects; Humans; Hyperlipidemias; Hypolipidemic Agents; Interferon-gamma; Metoprolol; Middle Aged; Myocardial Infarction; Polycythemia; Psoriasis; Risk Factors; Severity of Illness Index; Simvastatin; Triamcinolone Acetonide | 2019 |
Simvastatin in psoriasis: ambiguous effects.
Topics: Administration, Oral; Anti-Inflammatory Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Pilot Projects; Psoriasis; Severity of Illness Index; Simvastatin; Time Factors; Treatment Outcome | 2010 |
Psoriasis and psoriatic arthritis, axial type.
Topics: Antihypertensive Agents; Arthritis, Psoriatic; Etanercept; Humans; Hydrochlorothiazide; Hypolipidemic Agents; Immunoglobulin G; Lisinopril; Male; Middle Aged; Psoriasis; Receptors, Tumor Necrosis Factor; Simvastatin | 2001 |
Efficacy of simvastatin in plaque psoriasis: A pilot study.
Topics: Adult; Aged; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pilot Projects; Psoriasis; Severity of Illness Index; Simvastatin; Treatment Outcome | 2007 |